UC San Diego School of Medicine is among 27 research institutions selected to be part of the National Cancer Institute - funded Cancer
Immunotherapy Trials Network — to find agents that harness patients» immune systems to fight their cancer.
The Clinical Accelerator
network includes approximately 80 of the world's leading physician - scientists with expertise in tumor immunology and cancer
immunotherapy clinical
trials, immune monitoring, and correlative research.
Tags: aspirin, Bezos, bioengineering, Breast Cancer, Cameron Turtle, Cancer etiology - prevention - outcomes, CAR t - cell, Clinical Research, Colorectal Cancer, genome, hiv, hiv vaccine, hiv vaccine
trials network, Human Biology, immunology, Jason Bielas, Lawrence Corey, Matthias Stephan, merkel cell carcinoma, metastasis, Molecular basis of cancer, mylotarg, Obliteride, Paul Nghiem, philanthropy, Polly A Newcomb, Public Health Sciences, RNA, Ruth Etzioni, Soheil Meshinchi, Steven Henikoff, Transplant and
Immunotherapy, Tumor specific translational research, Vaccine and Infectious Disease, Vaccine development - Viral cancers
The Kimmel Cancer Center also participates in other cancer clinical
trials consortia, including those for prostate, breast, and bone marrow cancers,
immunotherapy, and the Hoosier Cancer Research
Network.